Xspray Pharma AB (publ) (OM: XSPRAY)
Health Care · Biotechnology · SE
Skr10.24
-0.58% today · -60.2% 1Y
Xspray Pharma AB (publ) (OM: XSPRAY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $48.91M and employs 24 people.
Over the last twelve months the share price has lost 60.2%, trading between 9.06 and 36.15.
Tweenvest scores Xspray Pharma AB (publ) across four factors: quality 46/100, value 19/100. Its strongest factor is quality.
XSPRAY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.91M
- Revenue (TTM)
- $254.44K
- P/E
- —
- EPS
- -3.82
- Dividend yield
- —
- Beta (5Y)
- -0.13
- 52-week high
- Skr36.15
- 52-week low
- Skr9.06
- Avg volume (3M)
- —
- Shares outstanding
- 47.42M
- Employees
- 24
- Next earnings
- —
About Xspray Pharma AB (publ)
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
- ISIN
- SE0009973563
- Founded
- 2003
- Listed since
- Sep 28, 2017
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alterity Therapeutics LimitedASX: ATH | $49.42M | AU$0.31 | -12.68% |
| iBio, Inc.NasdaqCM: IBIO | $49.28M | $0.77 | -12.02% |
| Adicet Bio, Inc.NasdaqCM: ACET | $49.19M | $4.57 | -18.54% |
| PanGen Biotech Inc.KOSDAQ: A222110 | $49.11M | ₩4,845.00 | +3.75% |
| Amicogen, Inc.KOSDAQ: A092040 | $48.83M | ₩924.00 | -6.29% |
| Optipharm.CO.,LTDKOSDAQ: A153710 | $48.80M | ₩4,435.00 | -1.22% |
| GENINUS Inc.KOSDAQ: A389030 | $48.75M | ₩1,650.00 | -15.38% |
| Connect Biopharma Holdings LimitedNasdaqGM: CNTB | $48.27M | $0.77 | +0.58% |
Figures last refreshed Oct 18, 2026.